Effects of the working experience, educational background, professional titles, and hospital grades of intensive care unit doctors on clinical glucocorticoid use in acute respiratory distress syndrome

被引:4
作者
Xuan, Nanxia [1 ]
Zhang, Xing [1 ,2 ]
Hu, Wenqing [1 ,3 ]
Chen, Guodong [1 ,4 ]
Wang, Yesong [1 ]
Zhang, Shufang [5 ]
Cui, Wei [1 ]
Zhang, Gensheng [1 ,6 ]
机构
[1] Zhejiang Univ, Dept Crit Care Med, Sch Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China
[2] Med Secur Bur Yinzhou Dist, Ningbo, Zhejiang, Peoples R China
[3] Zhejiang Univ, Haining Peoples Hosp, Dept Emergency Med, Haining Branch,Affiliated Hosp 1,Sch Med, Haining, Zhejiang, Peoples R China
[4] Zhejiang Univ, Dept Crit Care Med, Sch Med, Hosp Ningbo 1, Ningbo, Zhejiang, Peoples R China
[5] Zhejiang Univ, Dept Cardiol, Sch Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China
[6] Zhejiang Prov Clin Res Ctr Emergency & Crit Care, Hangzhou, Peoples R China
关键词
acute respiratory distress syndrome; glucocorticoid; intensive care unit; CORTICOSTEROID INSUFFICIENCY; MANAGEMENT; DIAGNOSIS; ARDS;
D O I
10.1097/MD.0000000000029021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although glucocorticoids are commonly used for patients with acute respiratory distress syndrome in the intensive care unit, the exact attitudes of different intensive care unit (ICU) doctors about glucocorticoid usage are largely unknown. Herein, we investigated the practice of glucocorticoid application for acute respiratory distress syndrome (ARDS) by ICU doctors in China. Questionnaires were developed and sent to ICU doctors at 45 hospitals to perform statistics and analysis. ICU doctors with more working experience and professional titles had more knowledge of ARDS. Glucocorticoids were more likely to be used for ARDS caused by chemical inhalation. Doctors with longer working experience, better educational background, and higher professional titles used fewer glucocorticoids. In addition, 97.2%of the doctors considered using methylprednisolone or hydrocortisone first, 50.9% used glucocorticoids within 24hours of onset, and 37.1% insisted that steroid therapy should last 3 to 5days. Although ICU doctors with more working experience and professional titles have a better understanding of glucocorticoid use in ARDS, the majority of clinical practices and attitudes are similar among different doctors regardless of working experience, educational background, professional titles, or hospital grades.
引用
收藏
页数:6
相关论文
共 23 条
[1]   Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017 [J].
Annane, Djillali ;
Pastores, Stephen M. ;
Rochwerg, Bram ;
Arlt, Wiebke ;
Balk, Robert A. ;
Beishuizen, Albertus ;
Briegel, Josef ;
Carcillo, Joseph ;
Christ-Crain, Mirjam ;
Cooper, Mark S. ;
Marik, Paul E. ;
Meduri, Gianfranco Umberto ;
Olsen, Keith M. ;
Rodgers, Sophia C. ;
Russell, James A. ;
Van den Berghe, Greet .
CRITICAL CARE MEDICINE, 2017, 45 (12) :2078-2088
[2]  
ASHBAUGH DG, 1967, LANCET, V2, P319
[3]   Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries [J].
Bellani, Giacomo ;
Laffey, John G. ;
Pham, Tai ;
Fan, Eddy ;
Brochard, Laurent ;
Esteban, Andres ;
Gattinoni, Luciano ;
van Haren, Frank ;
Larsson, Anders ;
McAuley, Daniel F. ;
Ranieri, Marco ;
Rubenfeld, Gordon ;
Thompson, B. Taylor ;
Wrigge, Hermann ;
Slutsky, Arthur S. ;
Pesenti, Antonio .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (08) :788-800
[4]   THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[5]   Steroids in ARDS: to be or not to be [J].
Bihari, Shailesh ;
Bailey, Michael ;
Bersten, Andrew D. .
INTENSIVE CARE MEDICINE, 2016, 42 (05) :931-933
[6]   Extracorporeal Membrane Oxygenation for ARDS in Adults [J].
Brodie, Daniel ;
Bacchetta, Matthew .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (20) :1905-1914
[7]  
Dushianthan A., 2021, J INTENS CARE SOC, P01
[8]   Perceptions of diagnosis and management of patients with acute respiratory distress syndrome: a survey of United Kingdom intensive care physicians [J].
Dushianthan, Ahilanandan ;
Cusack, Rebecca ;
Chee, Nigel ;
Dunn, John-Oliver ;
Grocott, Michael P. W. .
BMC ANESTHESIOLOGY, 2014, 14
[9]   Evaluation of knowledge and attitudes among intensive care physicians during the COVID-19 pandemic: a cross-sectional survey [J].
Erbas, Mesut ;
Dost, Burhan .
SAO PAULO MEDICAL JOURNAL, 2020, 138 (04) :317-321
[10]  
Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2022926, 10.1056/NEJMoa2021436]